IDH1 peptide vaccine (German Cancer Research Center)

N/A

Report date: 2022/09/02 20:00:31

Base Information

Drug NameIDH1 peptide vaccine (German Cancer Research Center)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionIsocitrate dehydrogenase [NADP] cytoplasmic inhibitors
TargetsIsocitrate dehydrogenase [NADP] cytoplasmic
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGerman Cancer Research Center (Dkfz)
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A